Amanote Research
Register
Sign In
Successful Treatment of Isohemagglutinin-Mediated Pure Red Cell Aplasia After ABO-mismatched Allogeneic Hematopoietic Cell Transplant Using Bortezomib
Bone Marrow Transplantation
- United Kingdom
doi 10.1038/bmt.2011.176
Full Text
Open PDF
Abstract
Available in
full text
Categories
Transplantation
Hematology
Date
August 29, 2011
Authors
L-M Poon
L P Koh
Publisher
Springer Science and Business Media LLC
Related search
Refractory Post‐Allogeneic Stem Cell Transplant Pure Red Cell Aplasia in Remission After Treatment With Daratumumab
American Journal of Hematology
Hematology
Pure Red Cell Aplasia After Allogeneic Stem Cell Transplantation With Reduced Conditioning
Bone Marrow Transplantation
Transplantation
Hematology
Allogeneic Stem Cell Transplantation for Acquired Pure Red Cell Aplasia
American Journal of Hematology
Hematology
Pure Red Cell Aplasia After Kidney Transplantation
American Journal of Transplantation
Transplantation
Allergy
Immunology
Pharmacology
Emtricitabine-Induced Pure Red Cell Aplasia
Southern African Journal of HIV Medicine
Infectious Diseases
Treatment of Pure Red Cell Aplasia After Major ABO-incompatible Peripheral Blood Stem Cell Transplantation by Induction of Chronic Graft-Versus-Host Disease
Bone Marrow Transplantation
Transplantation
Hematology
Successful Therapy of Pure Red Cell Aplasia Secondary to Plasma Cell Dyscrasia With Bolus Methylprednisolone.
Internal Medicine
Internal Medicine
Medicine
Characteristics of Late Fatal Infections After Allogeneic Hematopoietic Cell Transplant
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Critical Role of Mismatched HLA in Hemorrhagic Cystitis After Haploidentical Hematopoietic Stem Cell Transplant.
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
